Antimicrobial susceptibility profiles among common respiratory tract pathogens: A GLOBAL perspective

Postgraduate Medicine

Volumn 120, Issue 3, 2008, Pages

  Sahm, Daniel F ^a   Brown, Nina P ^a   Thornsberry, Clyde ^a   Jones, Mark E ^a  

^a Eurofins Medinet Inc   (Germany)

Author keywords

Antimicrobial resistance; Azithromycin; Haemophilus influenzae; Levofloxacin; Moraxella catarrhalis; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; SULFONAMIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; BACTERIUM ISOLATE; CENTRAL AMERICA; ENZYME SYNTHESIS; EUROPE; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PREVALENCE; RESPIRATORY TRACT INFECTION; SOUTH AFRICA; SOUTH AMERICA; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; DRUG EFFECT; HEALTH; HEALTH SURVEY; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; WORLD HEALTH;

EID: 66849125718     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2008.09.suppl52.280     Document Type: Article

References (15)

1. Hoban D, Baquero F, Reed V, Felmningham D. Demographic analysis of antimicrobial resistance among Streptococcus pneumoniae: worldwide results from PROTEKT 1999-2000. Int J Infect Dis. 2005;9(5):262-273.
2. Jones ME, Blosser-Middleton RS, Critchley IA, et al. The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000. Chemotherapy. 2002;48(5):232-237.
3. Hoban D, Felmingham D. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory traet infections. J Antimicrob Chemother. 2002;50(suppl 1):49-59. (Pubitemid 35049519)
4. Blosser-Middleton R, Sahm DF, Thornsberry C, et al. Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001. Clin Microbiol Infect. 2003;9(5);431-436.
5. Felmingham D. Comparative antimicrobial susceptibility of respiratory tract pathogens. Chemotherapy. 2004;50(suppl 1):3-10. (Pubitemid 39179214)
6. Jones ME, Blosser-Middleton RS, Thornsberry C, et al. The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002. Diagn Microbial Infect Dis. 2003;47(4):579-586.
7. Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32(suppl 2):S81-S93.
8. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN; The Alexander Project Group. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother. 2003;52(2):229-246.
9. Felmingham D, Reinert RR, Hirakata Y, Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother. 2002;50(suppl 1):25-37.
10. Ho PL, Que TL, Chiu SS, et al. Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001. Emerg Infect Dis. 2004;10(7):1250-1257.
11. Ho PL, Tse WS, Tsang KW, et al. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin Infect Dis 2001;32(5).701-707. (Pubitemid 32221927)
12. Ho PL, Que TL, Tsang DN, Ng TK, Chow KH, Seto WH. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother. 1999;43(5):1310-1313. (Pubitemid 29214773)
13. Sahm DF, Jones ME, Hickey ML, et al. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998. J Antimicrob Chemother. 2000;45(4):457-466.
14. Blosser RS, Sahm DF, Thornsberry C, Jones ME. A current perspective of antimicrobial resistance among respiratory infections worldwide: results from the GLOBAL surveillance. Presented at: 43rd Interscience Conference of Antimicrobial Agents and Chemotherapy; September 2003; Chicago, IL. Abstract C2-1260.
15. Johnson DM, Sader HS, Fritsche TR, Biedenbach DJ, Jones RN. Susceptibility trends of Haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis. 2003;47(1):373-376. (Pubitemid 37101172)